Suppr超能文献

相似文献

1
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
Gene. 2016 Jan 15;576(1 Pt 1):14-21. doi: 10.1016/j.gene.2015.09.058. Epub 2015 Sep 26.
2
Interferon target-gene expression and epigenomic signatures in health and disease.
Nat Immunol. 2019 Dec;20(12):1574-1583. doi: 10.1038/s41590-019-0466-2. Epub 2019 Nov 19.
4
Type I Interferons in Autoimmune Disease.
Annu Rev Pathol. 2019 Jan 24;14:369-393. doi: 10.1146/annurev-pathol-020117-043952. Epub 2018 Oct 17.
5
Genetic associations in type I interferon related pathways with autoimmunity.
Arthritis Res Ther. 2010;12 Suppl 1(Suppl 1):S2. doi: 10.1186/ar2883. Epub 2010 Apr 14.
6
Regulation of type I interferon responses.
Nat Rev Immunol. 2014 Jan;14(1):36-49. doi: 10.1038/nri3581.
7
Type I interferons (alpha/beta) in immunity and autoimmunity.
Annu Rev Immunol. 2005;23:307-36. doi: 10.1146/annurev.immunol.23.021704.115843.
8
[Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
Z Rheumatol. 2016 Mar;75(2):134-40. doi: 10.1007/s00393-015-0027-5.
9
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Pharmacol Res. 2013 Oct;76:1-8. doi: 10.1016/j.phrs.2013.06.007. Epub 2013 Jul 2.
10
JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.
Immunity. 2012 Apr 20;36(4):542-50. doi: 10.1016/j.immuni.2012.03.014.

引用本文的文献

1
Taming renal inflammation: signaling pathways and therapeutic advances in lupus nephritis.
BMC Nephrol. 2025 Sep 1;26(1):507. doi: 10.1186/s12882-025-04434-3.
2
Decrypting the Immune Symphony for RNA Vaccines.
Vaccines (Basel). 2025 Aug 20;13(8):882. doi: 10.3390/vaccines13080882.
6
The CGAS-STING1 Pathway as a Mediator of Innate Immune Response in Cardiovascular Disease.
JACC Asia. 2025 Apr;5(4):516-527. doi: 10.1016/j.jacasi.2025.01.005. Epub 2025 Mar 18.
9
Causes and consequences of DNA double-stranded breaks in cardiovascular disease.
Mol Cell Biochem. 2025 Apr;480(4):2043-2064. doi: 10.1007/s11010-024-05131-9. Epub 2024 Oct 15.
10
Differential type I and type III interferon expression profiles in rheumatoid and juvenile idiopathic arthritis.
Front Med (Lausanne). 2024 Sep 27;11:1466397. doi: 10.3389/fmed.2024.1466397. eCollection 2024.

本文引用的文献

1
Interferon regulatory factors: critical mediators of human lupus.
Transl Res. 2015 Feb;165(2):283-95. doi: 10.1016/j.trsl.2014.10.002. Epub 2014 Oct 13.
2
Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients.
PLoS One. 2014 Nov 14;9(11):e112758. doi: 10.1371/journal.pone.0112758. eCollection 2014.
6
Pathology of multiple sclerosis: where do we stand?
Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):901-21. doi: 10.1212/01.CON.0000433291.23091.65.
7
Interferon-α suppresses cAMP to disarm human regulatory T cells.
Cancer Res. 2013 Sep 15;73(18):5647-56. doi: 10.1158/0008-5472.CAN-12-3788. Epub 2013 Jul 22.
10
Vasculitis associated with tumor necrosis factor-α inhibitors.
Mayo Clin Proc. 2012 Aug;87(8):739-45. doi: 10.1016/j.mayocp.2012.04.011. Epub 2012 Jul 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验